Buy Fong Pharmaceuticals With Both Hands

The FDA is agog over Fong's new arsenic oxide cure for hiccups. It treats a trivial condition. Its unsafe. No Panel would recommend its use. It has everything the FDA could ever want. Moreover, no patient will be in a position afterward to dispute its efficacy although a lucky few with robust constitutions may walk, albeit, shorn of all mental faculties. Fong will be the toast of the pharmaceutical industry as others rush to develop palliations for the side effects, thus ensuring bullish chart patterns for all. The PDUFA filing fees that will enure to the FDA will fund retention bonuses for legions of loyal, crotch scratching FDA minions in perpetuity. Thankfully, no inconvenient pressure groups exist to champion the cause of lowly, unlovable hiccupers with such an unfashionable affliction.